← AVAH
AVAH— Aveanna Healthcare Holdings, Inc.
| Metric | FY2026 | FY2024 | FY2023 | FY2022 | FY2022 | FY2022 | FY2021 | FY2021 | FY2019 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.43B+20.2% | $2.02B+6.8% | $1.90B+0.0% | $1.90B+6.0% | $1.79B+6.5% | $1.68B+0.0% | $1.68B+21.3% | $1.38B | — |
| Cost of revenue, excluding depreciation and amortization | $1.62B+16.8% | $1.39B+6.9% | $1.30B+0.0% | $1.30B+5.3% | $1.23B+8.6% | $1.14B+0.0% | $1.14B+17.8% | $964.8M | — |
| Branch and regional administrative expenses | $374.5M+6.1% | $352.8M-2.3% | $361.0M+0.0% | $361.0M+1.0% | $357.2M+20.1% | $297.4M+0.0% | $297.4M+30.6% | $227.8M | — |
| Corporate expenses | $163.3M+30.2% | $125.4M+10.9% | $113.0M+0.0% | $113.0M-18.0% | $137.9M+5.7% | $130.4M+1762.7% | $7.0M-93.9% | $113.8M+0.5% | $113.2M |
| Depreciation and amortization | $10.5M-2.2% | $10.8M-21.8% | $13.8M+0.0% | $13.8M-35.4% | $21.3M+3.7% | $20.6M+0.0% | $20.6M+43.5% | $14.3M | — |
| Acquisition-related costs | $3.8M+155.9% | $1.5M+219.7% | $466K+0.0% | $466K+370.7% | $99K-99.2% | $12.8M+0.0% | $12.8M-43.4% | $22.7M | — |
| Other operating expense | $1.9M-64.7% | $5.3M+187.4% | -$6.0M+0.0% | -$6.0M-265.2% | $3.7M+1183.4% | -$337K+0.0% | -$337K-114.5% | $2.3M | — |
| Operating income | $256.5M+83.5% | $139.8M+1631.8% | $8.1M+0.0% | $8.1M+101.3% | -$642.3M-1678.6% | -$36.1M+0.0% | -$36.1M-192.7% | $39.0M | — |
| Interest income | $2.8M+468.5% | $498K+52.3% | $327K+0.0% | $327K-51.8% | $679K+168.4% | $253K+0.0% | $253K+22.2% | $207K | — |
| Interest expense | -$140.1M+10.5% | -$156.6M-2.2% | -$153.2M+0.0% | -$153.2M-42.3% | -$107.7M-56.3% | -$68.9M+0.0% | -$68.9M+25.3% | -$92.3M | — |
| Loss on debt extinguishment | -$5.9M | $0 | — | — | — | — | -$400K-447.9% | -$73K+98.5% | -$4.9M |
| Other (expense) income | -$6.4M-129.9% | $21.4M+265.6% | $5.9M+0.0% | $5.9M-93.2% | $85.5M+1640.0% | $4.9M+0.0% | $4.9M+128.8% | -$17.0M | — |
| Income before income taxes | $106.9M+2008.6% | $5.1M+103.6% | -$139.0M+0.0% | -$139.0M+79.1% | -$663.8M-484.5% | -$113.6M+0.0% | -$113.6M-51.4% | -$75.0M | — |
| Income tax benefit (expense) | $118.1M+838.0% | -$16.0M-457.8% | $4.5M+0.0% | $4.5M+151.2% | $1.8M+151.3% | -$3.5M+0.0% | -$3.5M-133.4% | -$1.5M | — |
| Net income (loss) | $225.0M+2159.1% | -$10.9M+91.9% | -$134.5M+0.0% | -$134.5M+79.7% | -$662.0M-465.6% | -$117.0M+0.0% | -$117.0M-53.0% | -$76.5M | — |
| Net income (loss) per share, basic | $1K+1950.0% | -$60+91.5% | -$710+0.0% | -$710+80.1% | -$4K-417.4% | -$690 | — | — | — |
| Weighted average shares of common stock outstanding, basic | $203.5M+5.5% | $192.9M+1.5% | $190.0M+0.0% | $190.0M+2.4% | $185.6M+8.7% | $170.6M | — | — | — |
| Net income (loss) per share, diluted | $1K+1850.0% | -$60+91.5% | -$710+0.0% | -$710+80.1% | -$4K-417.4% | -$690 | — | — | — |
| Weighted average shares of common stock outstanding, diluted | $215.0M+11.4% | $192.9M+1.5% | $190.0M+2.4% | $185.6M+0.0% | $185.6M+8.7% | $170.6M | — | — | — |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.